% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

shredmonkey 1 post  |  Last Activity: Jun 2, 2016 4:32 PM Member since: Jan 10, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    $300M - 500M

    by stalyon52 Jun 2, 2016 7:31 AM
    shredmonkey shredmonkey Jun 2, 2016 4:32 PM Flag

    flop-napt you mean? My brother is a pharmacist (he introduced me to TTNP, TTP back then) on the premise of iloperdone. That was about 10 years ago now, embarrassing to admit but true. I dont bother posting her much but you old timers know I am legit here and know titan well..

    Anyways, yes its true Sunil and titan were able to keep the company alive by trading flopnapt, which as we all know, did turn out to be basically worthless, so good for them for peddling junk, i guess? Not really.

    So it that what is going on with probuphine now?

    I got greedy on the approval day last week, saw the stock over 9 AH and put in a limit sell all or none just over $10....obviously didnt execute....then watched the stock tank friday morning, but held thinking (foolishly, and I should know better!!) that maybe just maybe we would get a ROW partner on the CC and spike again. I never believed a buyout was on the table for the CC.

    At least this time I am comfortable sitting on the shares for now as we have $$ coming, and I do think ROW is in play here, and there is considerable risk and uncertainty removed (around immediate cash needs only), but agree with others this POS could drift down a bit more, but I do think eventually we will hit around $10....and I will be out forever.

    This company is lousy, in terms of shareholder / market cap growth, that is hard to argue TTTNP market cap perpetually goes between zer, to ~150M. The pipeline today is far weaker than in previous times like when you had iloperidone, probuphine, chronic pain trials for probuphine (which i dont understand why they abandoned?), spheramine...etc.

    Sunil has raised so much over the years, with really no return to shareholders.

    We have one drug that may or may not succeed commercially (flopnapt being the only other comparable, with actual results)....the rest of the pipeline will take years and lots of $$, and really you have to believe people want to take implants to get behind this company at all.

5.470.00(0.00%)Aug 26 4:00 PMEDT